Literature DB >> 33095087

Infantile Inflammatory Myofibroblastic Tumor of Spleen.

Balamurugan Thirunavukkarasu1, Pritam Singha Roy2, Kirti Gupta1, Aravind Sekar1, Deepak Bansal2.   

Abstract

Background: Inflammatory myofibroblastic tumor (IMT) is a mesenchymal neoplasm with unknown etiology and recurrent potential. They are widely reported in children and young adults. Nearly 50% of inflammatory myofibroblastic tumor harbor rearrangement in anaplastic lymphoma kinase (ALK) gene with the majority expressing ALK protein. ALK-negative IMTs harbor alteration in ROS1 gene in a subset of cases. Few reports have shown association of IMT with Epstein-Barr virus (EBV). Case report: We report a case of IMT of the spleen in an 18-month-old infant presenting with abdominal distention and failure to thrive. Workup for ALK-1, ROS1, and EBV small-encoded RNA in-situ hybridization using immunohistochemistry was negative. Conclusions: IMT can arise in an infant spleen.

Entities:  

Keywords:  ALK; Epstein–Barr virus; Inflammatory myofibroblastic tumor; ROS1; spleen

Mesh:

Substances:

Year:  2020        PMID: 33095087     DOI: 10.1080/15513815.2020.1836098

Source DB:  PubMed          Journal:  Fetal Pediatr Pathol        ISSN: 1551-3815            Impact factor:   0.958


  1 in total

1.  Treatment of Pediatric Inflammatory Myofibroblastic Tumor: The Experience from China Children's Medical Center.

Authors:  Youhong Dong; Kashif Rafiq Zahid; Yidi Han; Pengchao Hu; Dongdong Zhang
Journal:  Children (Basel)       Date:  2022-02-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.